Méndez William, Rodgers Steven E, Lew John I, Montano Raquel, Solórzano Carmen C
Department of Surgery, University of Puerto Rico School of Medicine, San Juan, PR, USA.
Ann Surg Oncol. 2008 Sep;15(9):2487-92. doi: 10.1245/s10434-008-0052-6. Epub 2008 Jul 12.
Certain ultrasound features can predict malignancy in patients with thyroid nodules. The purpose of this study was to determine the value of surgeon-performed ultrasound (SUS) in predicting thyroid malignancy in patients with indeterminate fine-needle aspiration (FNA) cytology.
477 consecutive patients with dominant thyroid nodules were referred to our institution from 2002 to 2007. Of these, 180/477(38%) were judged to have indeterminate cytology: follicular neoplasm (FN, n = 108), Hürthle neoplasm (HN, n = 29), and suspicious for papillary thyroid cancer (SPTC, n = 43). SUS characteristics for thyroid nodules were recorded in a prospective database prior to thyroidectomy. Variables analyzed included patients' age and sex, nodule size, shape, echogenicity, consistency, borders, multiplicity/multicentricity, and presence of microcalcifications. SUS features of thyroid nodules were correlated with final pathology. The accuracy of individual SUS features as well as the presence of two or more adverse features in predicting malignancy was also examined.
There were 144 females and 36 males. Mean age was 52 years (range 17-87 years). Mean tumor size was 2.7 cm (range 0.65-6.6 cm). Overall, final pathology revealed cancer in 92/180 (51%) patients. Malignancy was present in 40/108 (37%) FN, 12/29 (41%) HN, and 40/43 (93%) SPTC. Nodule borders (irregular), shape (height > width), hypoechogenicity, and presence of microcalcifications were significantly associated with malignancy. The presence of 2 or >/=3 adverse SUS thyroid nodule features was associated with a >/=55% or >/=78% risk of malignancy, respectively.
Adverse thyroid nodule features seen on SUS may predict malignancy and help determine the initial extent of thyroidectomy in patients with indeterminate FNA cytology.
某些超声特征可预测甲状腺结节患者的恶性病变。本研究的目的是确定外科医生实施的超声检查(SUS)在预测细针穿刺(FNA)细胞学检查结果不确定的患者甲状腺恶性病变中的价值。
2002年至2007年,477例连续性甲状腺优势结节患者被转诊至我院。其中,180/477(38%)例患者的细胞学检查结果不确定:滤泡性腺瘤(FN,n = 108)、许特莱细胞瘤(HN,n = 29)以及可疑甲状腺乳头状癌(SPTC,n = 43)。在甲状腺切除术前,将甲状腺结节的SUS特征记录在前瞻性数据库中。分析的变量包括患者的年龄和性别、结节大小、形状、回声、质地、边界、多发性/多中心性以及微钙化的存在情况。甲状腺结节的SUS特征与最终病理结果相关。还检查了个体SUS特征以及两个或更多不良特征在预测恶性病变方面的准确性。
女性144例,男性36例。平均年龄52岁(范围17 - 87岁)。平均肿瘤大小为2.7 cm(范围0.65 - 6.6 cm)。总体而言,最终病理显示92/180(51%)例患者患有癌症。40/108(37%)例FN、12/29(41%)例HN以及40/43(93%)例SPTC为恶性。结节边界(不规则)、形状(高>宽)、低回声以及微钙化的存在与恶性病变显著相关。存在2个或≥3个不良SUS甲状腺结节特征分别与≥55%或≥78%的恶性风险相关。
SUS所见的不良甲状腺结节特征可能预测恶性病变,并有助于确定FNA细胞学检查结果不确定的患者甲状腺切除术的初始范围。